Pancreatitis and gallbladder issues: Severe abdominal pain that radiates to the back, nausea, fever, or vomiting while using GLP-1s may indicate inflammation of the pancreas, while upper right abdominal pain, jaundice, fever, and nausea can be due to gallbladder issues such as gallstones
Headaches Less common but reported by some users, particularly in the first two weeks
During your initial visit, you will connect with your doctor on your smart phone or computer
Instead of relying on GLP-1 for weight loss without obesity , it may be more beneficial to: Follow a balanced diet with adequate protein Engage in strength training to maintain muscle mass Use lifestyle interventions to sustain weight Risks of Weight Loss Injections for Non-Overweight Individuals There are several weight loss injection risks for non-overweight individuals, including: Metabolic changes that could disrupt natural hunger signals Muscle loss rather than fat loss Increased risk of hypoglycemia Long-term unknown effects on overall health Weight Loss Injections vs
Key facts Blue Cross Blue Shield of Massachusetts ended weight-loss GLP-1 coverage effective January 1, 2026 a regional signal of cost pressure that Harvard Pilgrim members in New England should factor into their coverage verification
Observed Weight Trends Longer clinical trials have reported reduction in body weight over extended observation periods
